Tobin James R
- SEC CIK
- 0001190128
In the past year, 1 open-market sale filing worth $2.24M and no purchases.
Current role at each company
- GMED Globus Medical IncDirectoras of Sep 16, 2026
- TMDX TransMedics Group, Inc.Directoras of Aug 17, 2026
- LYRA Lyra Therapeutics, Inc.Directoras of May 16, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.24M
- 1 filing
- Net
- −$2.24M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Tobin James R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GMED Globus Medical Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 (view filing)4:35 PM ET | Sep 15 | 1 day | Tobin James RDirector | SSaleClass A Common Stock | −30.0K | $74.58 | −$2.24M | −100.0%0 after | |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Tobin James RDirector | SSaleClass A Common Stock | −8.85K | $65.47 | −$579.4K | −100.0%0 after | |
| Mar 10, 2022 (view filing) | Mar 8-10 | 2 days | Tobin James RDirector | SSaleClass A Common Stock | −14.5K | $70.65 | −$1.02M | −100.0%0 after | 2 lots |
TMDX TransMedics Group, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2024 (view filing) | Aug 8 | 1 day | Tobin James RDirector | SSale | −20.0K | $159.33 | −$3.19M | −10.4%173.1K after | 2 lots |
| May 7, 2024 (view filing) | May 3 | 4 days | Tobin James RDirector | SSale | −12.0K | $125.05 | −$1.50M | −5.9%193.1K after | 2 lots10b5-1 |
| May 3, 2024 (view filing) | May 1 | 2 days | Tobin James RDirector | SSale | −15.0K | $106.43 | −$1.60M | −6.8%205.2K after | 4 lots10b5-1 |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Tobin James RDirector | SSale | −13.4K | $83.63 | −$1.12M | −5.7%220.2K after | 5 lots10b5-1 |
| Nov 29, 2023 (view filing) | Nov 28 | 1 day | Tobin James RDirector | SSale | −10.0K | $70.14 | −$701.4K | −4.1%233.6K after | |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Tobin James RDirector | SSale | −10.0K | $75.13 | −$751.3K | −3.9%243.6K after | |
| Aug 1, 2022 (view filing) | Jul 29 | 3 days | Tobin James RDirector | SSale | −48.5K | $39.98 | −$1.94M | −16.1%253.6K after | |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Tobin James RDirector | SSale | −48.5K | $35.00 | −$1.70M | −13.8%302.1K after | |
| May 6, 2022 (view filing) | May 4 | 2 days | Tobin James RDirector | SSale | −48.5K | $29.94 | −$1.45M | −12.2%350.6K after |